Funded Startups in Winston Salem
Among the 27 listed Winston Salem–area funding events, the largest disclosed amount is Javara Research’s $9M round dated 2023-11-08; that figure materially…
Among the 27 listed Winston Salem–area funding events, the largest disclosed amount is Javara Research’s $9M round dated 2023-11-08; that figure materially exceeds the next-largest disclosed rounds shown (e.g., Fluree’s $8M on 2022-10-13 and several sub-$3M disclosed amounts like Wellnecity’s $3M on 2022-01-11). The disclosed-size distribution also has a clear low end: the smallest disclosed amount is $50K (CopyForward on 2022-05-12 and also Plakous Therapeutics’ $60K is near the bottom), while many entries are undisclosed.
Stage and classification are skewed toward non-specified amounts and series labels: 20 of 27 rows are marked “undisclosed,” and 24 of 27 rows have “Series Unknown” or a blank series label (only a few specify Seed, Pre-Seed, Venture, Series A, Grant, Debt Financing, or Non-equity Assistance). Temporally, the most recent activity is concentrated in the last 12 months, with entries dated 2025-01-03 through 2026-05-19 (e.g., Charter Medical on 2026-05-19 and Postbiotics on 2026-02-09), while the oldest row shown dates to 2020-06-25 (F5 Sports, $4M). Sector-wise, Biotechnology shows up repeatedly (Charter Medical 2026-05-19; Piedmont Stone Center 2023-01-12; Precise Bio 2022-07-18; and others), creating a biotech cluster across multiple years.
Most recent rounds
27 shownRelated listings
Frequently asked
What stands out about disclosed round sizes in Winston Salem here?
Javara Research’s $9M (2023-11-08) is the largest disclosed amount, and it sits above most other disclosed rounds in this list; Fluree’s $8M (2022-10-13) is the next-highest disclosed amount. At the low end, CopyForward’s $50K (2022-05-12) is the smallest disclosed figure among the rows with disclosed amounts.
Do the most recent funding rounds cluster tightly by date?
Yes. The page includes multiple rounds within the last year of the dataset, running from 2025-01-03 (The Flawlesskin Company) through 2026-05-19 (Charter Medical). Earlier activity spans down to 2020-06-25 (F5 Sports, $4M), indicating the list covers several distinct periods rather than a single burst.
Are sectors or themes over-represented compared to the rest?
Biotechnology is one of the most recurring sectors in the rows shown, appearing at least with Charter Medical (2026-05-19), Piedmont Stone Center (2023-01-12), Precise Bio (2022-07-18), and KeraVet Bio (2023-04-04). In contrast, several other sectors appear once or twice (e.g., Gaming: XPAND Gaming 2022-03-21 and F5 Sports 2020-06-25).
How much of the list is effectively “unquantified” due to missing disclosed amounts or series labels?
Disclosed amounts are missing for 20 of 27 rows (“undisclosed”), and series classification is similarly sparse: 24 of 27 rows show “Series Unknown” or a blank series field. Only a minority include explicit stage/structure labels, such as mPath Health (Seed, $1M on 2024-10-21) and Wellnecity (Series A, $3M on 2022-01-11).
Which entries look like size outliers worth double-checking for strategy and comparables?
On disclosed amounts, the upper tail includes Javara Research’s $9M (2023-11-08) and Fluree’s $8M (2022-10-13), which sit above many other disclosed rounds like OrbitalRx’s $1M (2025-10-20) and Senior Services’ $500K (2023-02-20). On stage label mix, the presence of non-equity and grant-style events (e.g., inStryde $100K as Non-equity Assistance on 2022-03-21 and Wake Forest Baptist Medical Center’s $3M Grant on 2022-04-12) can complicate comparisons when assessing momentum by dollar size alone.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.